Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Is LDL-C passed its prime? The emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessment.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Is LDL-C passed its prime? The emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessment.
Is LDL-C passed its prime? The emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessment. Arterioscler Thromb Vasc Biol. 2008 Sep; 28(9):1582-3.
View in:
PubMed
subject areas
Apolipoproteins B
Biomarkers
Cholesterol, LDL
Coronary Disease
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipoproteins, LDL
Patient Selection
Risk Assessment
authors with profiles
Michael H. Davidson